Celldex Therapeutics
CLDX
CLDX
176 hedge funds and large institutions have $2.44B invested in Celldex Therapeutics in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 68 increasing their positions, 55 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $2.58B → $2.44B (-$135M)
21% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 28
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
176
Holding in Top 10
4
Calls
$61.1M
Puts
$35.8M
Top Buyers
| 1 | +$59M | |
| 2 | +$53.8M | |
| 3 | +$39.7M | |
| 4 |
Goldman Sachs
New York
|
+$32.7M |
| 5 |
LGM
Logos Global Management
San Francisco,
California
|
+$30.6M |
Top Sellers
| 1 | -$61.3M | |
| 2 | -$37.4M | |
| 3 | -$20.3M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$12.6M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$12.1M |